Cancer Genomics

Germline HRR Panel

$699

Evaluation of genes involved in Homologous Recombination Repair (HRR), important in assessing hereditary cancer risk and potential targeted therapies.

Targeted Therapy & Risk Assessment

Our HRR Panel provides advanced genetic testing designed to identify inherited risks associated with the DNA repair pathway. This information is critical for supporting precision medicine and informed treatment planning.

Hereditary Risk: Assessment of mutations associated with prostate, ovarian, and pancreatic cancers.
Treatment Guidance: Insights that may help identify candidates for PARP inhibitors and other targeted therapies.
Expert Interpretation: High-quality technological analysis interpreted by experienced specialists.

Begin Your Journey

Let's discuss how we can elevate your health and wellness strategy. Experience healthcare as it was meant to be.

Priority Hotline Available

Dubai, United Arab Emirates